⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

June 4, 2024Open Access

Figure S8 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy

Michael V. Martin Salvador Aguilar-Rosas Katka Franke Mark Pieterse Jamie van Langelaar Renée Schreurs Maarten F. Bijlsma Marc G. Besselink Jan Köster Wim Timens Mustafa Khasraw David M. Ashley Stephen T. Keir Christian H. Ottensmeier Emma V. King Joanne Verheij Cynthia Waasdorp Peter J.M. Valk Sem A.G. Engels Ellen Oostenbach Jip T. van Dinter Damon A. Hofman Juk Yee Mok Wim J.E. van Esch Hanneke Wilmink Kim Monkhorst Henk M.W. Verheul Dennis Poel T. Jeroen N. Hiltermann Léon C.L.T. van Kempen Harry J.M. Groen Joachim G.J.V. Aerts Sebastiaan van Heesch Bob Löwenberg Ronald H.A. Plasterk Wigard P. Kloosterman

View Full Paper

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

Figure S8: Comparison of EasyFuse short-read fusion gene caller with long-read and WGS guided NOP identification.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Martin et al. (2024) studied this question.

synapsesocial.com/papers/68e664bab6db6435875f12d2 https://doi.org/10.1158/2326-6066.25964328

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Figure S5 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy2024
2Figure S9 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy2024
3Figure S1 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy2024
4Figure S10 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy2024
5Figure S6 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy2024

Figure S11 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy2024
Figure S4 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy2024
Figure S2 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy2024